Prescription Drug User Fee Act V Benefit-Risk Plan

Document ID: FDA-2013-N-0196-0001

Comments

Total: 14
National Organization for Rare Disorders- Comment
Posted : 05/13/2013     ID :FDA-2013-N-0196-0002     Agency : FDA

May 07,2013 11:59 PM ET
Accelerate Cure/Treatments for Alzheimer's Disease - Comment
Posted : 05/13/2013     ID :FDA-2013-N-0196-0003     Agency : FDA

May 07,2013 11:59 PM ET
Centre for Innovation in Regulatory Science - Comment
Posted : 05/13/2013     ID :FDA-2013-N-0196-0004     Agency : FDA

May 07,2013 11:59 PM ET
National Brain Tumor Society - Comment
Posted : 05/13/2013     ID :FDA-2013-N-0196-0005     Agency : FDA

May 07,2013 11:59 PM ET
National Organization for Rare Disorders (NORD) - Comment
Posted : 05/13/2013     ID :FDA-2013-N-0196-0006     Agency : FDA

May 07,2013 11:59 PM ET
Children's Cause for Cancer Advocacy - Comment
Posted : 05/13/2013     ID :FDA-2013-N-0196-0007     Agency : FDA

May 07,2013 11:59 PM ET
National Psoriasis Foundation - Comment
Posted : 05/21/2013     ID :FDA-2013-N-0196-0008     Agency : FDA

May 07,2013 11:59 PM ET
Pharmaceutical Research and Manufacturers of America (PhRMA) - Comment
Posted : 05/21/2013     ID :FDA-2013-N-0196-0009     Agency : FDA

May 07,2013 11:59 PM ET
Biotechnology Industry Organization (BIO) - Comment
Posted : 05/21/2013     ID :FDA-2013-N-0196-0010     Agency : FDA

May 07,2013 11:59 PM ET
Roche Genentech - Comment
Posted : 05/21/2013     ID :FDA-2013-N-0196-0011     Agency : FDA

May 07,2013 11:59 PM ET
National Health Council - Comment
Posted : 05/21/2013     ID :FDA-2013-N-0196-0012     Agency : FDA

May 07,2013 11:59 PM ET
The Leukemia & Lymphoma Society - Comment
Posted : 05/21/2013     ID :FDA-2013-N-0196-0013     Agency : FDA

May 07,2013 11:59 PM ET
Cystic Fibrosis Foundation - Comment
Posted : 05/21/2013     ID :FDA-2013-N-0196-0014     Agency : FDA

May 07,2013 11:59 PM ET
Cancer Leadership Council - Comment
Posted : 05/21/2013     ID :FDA-2013-N-0196-0015     Agency : FDA

May 07,2013 11:59 PM ET